Trial Profile

A Phase II, Double-Blind, Placebo-Controlled, Multi-Centre, Randomised Study of ZD4054 Plus Carboplatin and Paclitaxel or Placebo Plus Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer Sensitive to Platinum-Based Chemotherapy.

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 05 May 2013

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

06 Aug 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
05 Jun 2012 Actual patient number is 120 according to ClinicalTrials.gov.
05 Aug 2011 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com